Cisplatin plus vinorelbine as a salvage regimen in refractory breast cancer

Gunel N., Akcali Z., Yamac D., Onuk E., Yilmaz E., Bayram O., ...Daha Fazla

TUMORI, cilt.86, sa.4, ss.283-285, 2000 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 86 Sayı: 4
  • Basım Tarihi: 2000
  • Doi Numarası: 10.1177/030089160008600404
  • Dergi Adı: TUMORI
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.283-285
  • Gazi Üniversitesi Adresli: Evet

Özet

Aims and background: Breast cancer refractory to known effective agents is one of the major clinical problems frequently encountered in practice. Cisplatin and vinorelbine are known to be active drugs in anthracycline-refractory cases. In this phase II study, the effectiveness and tolerability of cisplatin and vinorelbine was investigated when used in combination as a salvage regimen In the treatment of metastatic refractory breast cancer.